The evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus--the good, the bad, and the flawed!
Gastric acid is believed to be an important etiological factor in the pathogenesis of Barrett's esophagus. Pulsatile acid exposure increases cell proliferation in ex vivo Barrrett's tissue and normalization of esophageal pH reverses this. Proton pump inhibitors (PPIs) are the mainstay of t...
Principais autores: | Leedham, S, Jankowski, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2007
|
Registros relacionados
-
Proton Pump Inhibitors (PPIs): The culprit for Barrett’s esophagus?
por: Omran eAlsalahi, et al.
Publicado em: (2015-01-01) -
Barrett’s Esophagus: Is It All That Bad?
por: GNJ Tytgat
Publicado em: (1999-01-01) -
Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
por: Harry Snady
Publicado em: (2023-12-01) -
Mapping clonality in individual glands in human Barrett's esophagus
por: Leedham, S, et al.
Publicado em: (2007) -
Gingers and Their Purified Components as Cancer Chemopreventative Agents
por: John F. Lechner, et al.
Publicado em: (2019-08-01)